Individual differences |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |
| CAS number |
| ATC code |
| PubChem |
| DrugBank |
|Routes of administration|
Androstenedione (also known as 4-androstenedione) is a 19-carbon steroid hormone produced in the adrenal glands and the gonads as an intermediate step in the biochemical pathway that produces the androgen testosterone and the estrogens estrone and estradiol.
The production of adrenal androstenedione is governed by ACTH, while production of gonadal androstenedione is under control by gonadotropins. In premenopausal women the adrenal glands and ovaries each produce about half of the total androstendione (about 3 mg/day). After menopause androstenedione production is about halved, primarily due to the reduction of steroid secreted by the ovary. Nevertheless, androstenedione is the principal steroid produced by the postmenopausal ovary.
Androstenedione as a supplementEdit
Androstenedione is manufactured as dietary supplement, often called andro (or andros) for short. Andro was in common use in Major League Baseball throughout the 1990s by record breaking sluggers like Mark McGwire, but it is unknown (and unknowable) to what extent andro was responsible for McGwire's exceptional performance. The supplement is banned by the World Anti-Doping Agency, and hence from the Olympic Games.
On March 12, 2004, the Anabolic Steroid Control Act of 2004 was introduced into the United States Senate. It amended the Controlled Substance Act to place both anabolic steroids and prohormones on a list of controlled substances, making possession of the banned substances a federal crime. The law took effect on January 20, 2005.
Conversion to estroneEdit
Because androstenedione is converted in part to estrogens, persons taking this supplement may have estrogenic side effects. A visible problem could be gynecomastia (formation of breast tissue) in males.
|This page uses Creative Commons Licensed content from Wikipedia (view authors).|